PAPER Mengel D, Röskam S, Neff F, Balakrishnan K, Deuster O, Gold M, Oertel WH, Bacher M, Bach JP, Dodel R

Naturally occurring autoantibodies interfere with β-amyloid metabolism and improve cognition in a transgenic mouse model of Alzheimer's disease 24 h after single treatment.

Transl Psychiatry. 2013;3:e236. PubMed.

PAPER Perneczky R, Guo LH, Kagerbauer SM, Werle L, Kurz A, Martin J, Alexopoulos P

Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's disease.

Transl Psychiatry. 2013 Feb 19;3:e227. PubMed.

PAPER Reitz C, Tosto G, Vardarajan B, Rogaeva E, Ghani M, Rogers RS, Conrad C, Haines JL, Pericak-Vance MA, Fallin MD, Foroud T, Farrer LA, Schellenberg GD, George-Hyslop PS, Mayeux R,

Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).

Transl Psychiatry. 2013;3:e256. PubMed.

PAPER Schmechtig A, Lees J, Perkins A, Altavilla A, Craig KJ, Dawson GR, William Deakin JF, Dourish CT, Evans LH, Koychev I, Weaver K, Smallman R, Walters J, Wilkinson LS, Morris R, Williams SC, Ettinger U

The effects of ketamine and risperidone on eye movement control in healthy volunteers.

Transl Psychiatry. 2013 Dec 10;3:e334. PubMed.

PAPER Trueba-Sáiz A, Cavada C, Fernandez AM, Leon T, González DA, Fortea Ormaechea J, Lleó A, Del Ser T, Nuñez A, Torres-Aleman I

Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice.

Transl Psychiatry. 2013 Dec 3;3:e330. PubMed.

PAPER Weisová P, Alvarez SP, Kilbride SM, Anilkumar U, Baumann B, Jordán J, Bernas T, Huber HJ, Düssmann H, Prehn JH

Latrepirdine is a potent activator of AMP-activated protein kinase and reduces neuronal excitability.

Transl Psychiatry. 2013;3:e317. PubMed.

PAPER Bakermans-Kranenburg MJ, van I Jzendoorn MH

Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy.

Transl Psychiatry. 2013 May 21;3(5):e258. PubMed.

PAPER Katz DA, Liu W, Locke C, Jacobson P, Barnes DM, Basu R, An G, Rieser MJ, Daszkowski D, Groves F, Heneghan G, Shah A, Gevorkyan H, Jhee SS, Ereshefsky L, Marek GJ

Peripheral and central nervous system inhibition of 11β-hydroxysteroid dehydrogenase type 1 in man by the novel inhibitor ABT-384.

Transl Psychiatry. 2013 Aug 27;3:e295. PubMed.

PAPER Begum AN, Cunha C, Sidhu H, Alkam T, Scolnick J, Rosario ER, Ethell DW

Women with the Alzheimer's risk marker ApoE4 lose Aβ-specific CD4⁺ T cells 10-20 years before men.

Transl Psychiatry. 2014 Jul 29;4:e414. PubMed.

PAPER Honarnejad K, Daschner A, Gehring AP, Szybinska A, Giese A, Kuznicki J, Bracher F, Herms J

Identification of tetrahydrocarbazoles as novel multifactorial drug candidates for treatment of Alzheimer's disease.

Transl Psychiatry. 2014 Dec 16;4:e489. PubMed.

PAPER Janel N, Sarazin M, Corlier F, Corne H, de Souza LC, Hamelin L, Aka A, Lagarde J, Blehaut H, Hindié V, Rain JC, Arbones ML, Dubois B, Potier MC, Bottlaender M, Delabar JM

Plasma DYRK1A as a novel risk factor for Alzheimer's disease.

Transl Psychiatry. 2014 Aug 12;4:e425. PubMed.

PAPER Lyall DM, Harris SE, Bastin ME, Muñoz Maniega S, Murray C, Lutz MW, Saunders AM, Roses AD, Valdés Hernández Md, Royle NA, Starr JM, Porteous DJ, Wardlaw JM, Deary IJ

Are APOE ɛ genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity?

Transl Psychiatry. 2014 Sep 23;4:e449. PubMed.

PAPER Mitsis EM, Riggio S, Kostakoglu L, Dickstein DL, Machac J, Delman B, Goldstein M, Jennings D, D'Antonio E, Martin J, Naidich TP, Aloysi A, Fernandez C, Seibyl J, DeKosky ST, Elder GA, Marek K, Gordon W, Hof PR, Sano M, Gandy S

Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury.

Transl Psychiatry. 2014 Sep 16;4:e441. PubMed.

PAPER Miyashita A, Hatsuta H, Kikuchi M, Nakaya A, Saito Y, Tsukie T, Hara N, Ogishima S, Kitamura N, Akazawa K, Kakita A, Takahashi H, Murayama S, Ihara Y, Ikeuchi T, Kuwano R, Japanese Alzheimer's Disease Neuroimaging Initiative

Genes associated with the progression of neurofibrillary tangles in Alzheimer's disease.

Transl Psychiatry. 2014 Jun 10;4:e396. PubMed.

PAPER Paterson RW, Bartlett JW, Blennow K, Fox NC, Alzheimer's Disease Neuroimaging Initiative, Shaw LM, Trojanowski JQ, Zetterberg H, Schott JM

Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.

Transl Psychiatry. 2014 Jul 29;4:e419. PubMed.